Skip to content

Cannabis research published in 2018

Page 6 of 6: studies 101 to 117 of 117, newest first. Back to the cannabis overview

Studies

Chronic Δ9-THC in Rhesus Monkeys: Effects on Cognitive Performance and Dopamine D2/D3 Receptor Availability.

Journal of Pharmacology and Experimental Therapeutics February 2018 William S John, Thomas J Martin, Kiran Kumar Solingapuram Sai et al.

Cannabis-related impairments to cognitive function may represent novel therapeutic targets for cannabis-use disorder, although the nature, persistence, and reversibility of such deficits remain unclear. Adult male rhesus monkeys (N = 6) responded in the morning on tasks designed to assess different cognitive domains using the Cambridge Neuropsychological Test Automated Battery (CANTAB)...

The effects of cannabis use on salience attribution: a systematic review.

Acta Neuropsychiatrica February 2018 Surapi Bhairavi Wijayendran, Aisling O'Neill, Sagnik Bhattacharyya

The relationship between cannabis use and the onset of psychosis is well established. Aberrant salience processing is widely thought to underpin many of these symptoms. Literature explicitly investigating the relationship between aberrant salience processing and cannabis use is scarce; with those few studies finding that acute tetrahydrocannabinol (THC) administration (the main psychoactive...

DOI: 10.1017/neu.2016.58 (opens in new tab) Full text (opens in new tab) Cannabis Cognition disorders Functional neuroimaging Marijuana smoking +1

Relating Observed Psychoactive Effects to the Plasma Concentrations of Delta-9-Tetrahydrocannabinol and Its Active Metabolite: An Effect-Compartment Modeling Approach.

Journal of Pharmaceutical Sciences February 2018 Rakesh Awasthi, Guohua An, Maureen D Donovan et al.

The medical use of marijuana is increasing, yet little is known about the exposure-response relationship for its psychoactive effects. It is well known that the plasma concentrations of the principal psychoactive component of marijuana, Δ9-tetrahydrocannabinol (THC), do not directly correlate to the observed psychoactive effects. The purpose of this research was to use an effect-compartment...

DOI: 10.1016/j.xphs.2017.09.009 (opens in new tab) Full text (opens in new tab) Clinical pharmacokinetics Metabolism Metabolite kinetics Pharmacokinetic/pharmacodynamic models +2

The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment

Frontiers in Pharmacology January 17, 2018 Staci A Gruber, Kelly A. Sagar, M. Dahlgren et al.

The vast majority of states have enacted full or partial medical marijuana (MMJ) programs, causing the number of patients seeking certification for MMJ use to increase dramatically in recent years. Despite increased use of MMJ across the nation, no studies thus far have examined the specific impact of MMJ on cognitive function and related brain activation. In the present study, MMJ patients...

Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects

Evidence-based Complementary and Alternative Medicine 2018 Nadia Gulluni, Tania Simona Re, Idalba Loiacono et al. 61 citations

We examined the effects of essential oil from legal (THC <0.2% w/v) hemp variety on the nervous system in 5 healthy volunteers. GC/EIMS and GC/FID analysis of the EO showed that the main components were myrcene and β‐caryophyllene. The experiment consisted of measuring autonomic nervous system (ANS) parameters; evaluations of the mood state; and electroencephalography (EEG) recording before...

Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.

Current Topics in Behavioral Neurosciences 2018 B Levi Bolin, Joseph L Alcorn, Anna R Reynolds et al.

Drug-discrimination procedures empirically evaluate the control that internal drug states have over behavior. They provide a highly selective method to investigate the neuropharmacological underpinnings of the interoceptive effects of drugs in vivo. As a result, drug discrimination has been one of the most widely used assays in the field of behavioral pharmacology. Drug-discrimination...

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol.

Neuropsychopharmacology January 2018 Douglas L Boggs, Jacques D. Nguyen, Daralyn Morgenson et al.

The plant Cannabis sativa, commonly called cannabis or marijuana, has been used for its psychotropic and mind-altering side effects for millennia. There has been growing attention in recent years on its potential therapeutic efficacy as municipalities and legislative bodies in the United States, Canada, and other countries grapple with enacting policy to facilitate the use of cannabis or its...

Leveraging user perspectives for insight into cannabis concentrates.

The American Journal of Drug and Alcohol Abuse 2018 Patricia A. Cavazos-Rehg, Melissa J Krauss, Shaina J Sowles et al.

The US has seen an increase in the popularity of highly concentrated forms of cannabis (hereafter concentrates) and too little is known about the potential risks associated with their use. The present study aims to better understand the patterns and outcomes of concentrates use through the perspectives of young adult users. Participants (N = 234, 27.9% female) aged 18-35 years were recruited...

Brain Changes during Cannabis-Induced Psychosis: Clarifying the Marijuana Medicine/Harm Dichotomy

Journal of psychiatry and brain science 2018 Pierre Flor-Henry, Yakov Shapiro 1 citation

Marijuana is the most widely consumed recreational drug in the world. In Canada, physicians are experiencing increasing pressure to prescribe medical marijuana, with proposed legalization coming in late 2018. The use of marijuana in the psychiatric population is increasing, and the prescribing process is largely unregulated. In spite of several medicinal indications, chronic marijuana use is...

Effect of repeated juvenile exposure to Δ9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats.

Neurotoxicology and Teratology 2018 Afzaal N Mohammed, Navatha Alugubelly, Barbara L Kaplan et al.

The gestational and adolescent periods are critically important for brain development and exposure to Δ9‑tetrahydrocannabinol (Δ9-THC) during these periods results in long term behavioral and biochemical abnormalities in laboratory animals. However, recent reports indicate a dramatic rise in oral Δ9-THC exposure in young children but the effects of this exposure scenario have not been...

Selective and Context-Dependent Social and Behavioral Effects of Δ9-Tetrahydrocannabinol in Weakly Electric Fish.

Brain, Behavior and Evolution 2018 Brandon Neeley, Tyler Overholt, Emily Artz et al.

Cannabinoid (CB) receptors are widespread in the nervous system and influence a variety of behaviors. Weakly electric fish have been a useful model system in the study of the neural basis of behavior, but we know nothing of the role played by the CB system. Here, we determine the overall behavioral effect of a nonselective CB receptor agonist, namely Δ9-tetrahydrocannabinol (THC), in the weakly...

DOI: 10.1159/000490171 (opens in new tab) Full text (opens in new tab) Apteronotus leptorhynchus Cannabinoid Communication Electric fish +4

Selective effects of Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum.

PLoS One 2018 Mónica R Fernández-Cabrera, Alejandro Higuera-Matas, Isabel Fernaud-Espinosa et al.

Derivatives from the Cannabis plant are the most commonly abused illegal substances in the world. The main psychoactive component found in the plant, Δ-9-tetrahydrocannabinol (THC), exerts its effects through the endocannabinoid system. Manipulations of this system affect some types of learning that seem to be dependent on dorsal striatum synaptic plasticity. Dendritic spines exhibit important...

A comparison of self-reported sexual effects of alcohol, marijuana, and ecstasy in a sample of young adult nightlife attendees.

Psychology and sexuality 2018 Joseph J Palamar, Marybec Griffin-Tomas, Patricia Acosta et al.

Alcohol, marijuana, and ecstasy (3,4-methylenedioxymethamphetamine [MDMA], 'Molly') are among the most prevalent substances used by young adults; however, few studies have focused on the specific sexual effects associated with use. Examining subjective sexual effects (e.g. increased libido) associated with use can inform prevention efforts. Data were analysed from 679 nightclub and dance...

The association of cannabis use on inpatient psychiatric hospital outcomes.

The American Journal of Drug and Alcohol Abuse 2018 Melanie Rylander, Helena R Winston, Haley Medlin et al.

The associations between cannabis use and psychosis are well documented in numerous studies. There is a need to evaluate the impact of cannabis use on inpatient psychiatric utilization and outcomes. To evaluate the impact of cannabis use on psychiatric hospital outcomes. This study was conducted between April 20, 2015 and October 20, 2015. All patients (n = 120) admitted to Denver Health with...

Self-Experiments with Psychoactive Substances: A Historical Perspective.

Handbook of experimental pharmacology 2018 Torsten Passie, Simon D. Brandt

The purpose of this chapter is to highlight the rich tradition of self-experiments (SEs) with psychoactive substances carried out by scientists and therapists for more than a century. Scientifically inspired controlled SEs dominated until the end of the twentieth century, when ethical requirements minimized controlled SEs and "wild" SEs expanded particularly with the emergence of new...

DOI: 10.1007/164_2018_177 (opens in new tab) Full text (opens in new tab) Cannabis Cocaine Dissociative hallucinogens Entactogens +3

Pharmacies as potential providers of harm reduction services: A preliminary online survey

Drug Science, Policy and Law 2018 Edward James, Thomas L Robertshaw, Andrew D. Westwell et al. 4 citations

Background Recreational drug use is a major cause of disease, injury, physical and mental impairment and death in developed countries such as the United Kingdom and the United States. Alcohol, tobacco, cannabis, 3,4-methylenedioxymethamphetamine (MDMA) and psilocybe mushrooms are recreational drugs with capacity to cause harm. Cannabis, MDMA and psilocybin have reported therapeutic...